Relationship between systemic 5-FU passage and response in colorectal cancer patients treated with intrahepatic chemotherapy
- 1 August 1987
- journal article
- conference paper
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 20 (1), 71-74
- https://doi.org/10.1007/bf00252963
Abstract
The study described herein was conducted to analyze the relationship between tumor exposure to 5-FU and clinical response. Six patients were placed on continuous 5-day intrahepatic 5-FU chemotherapy for colorectal cancer metastasized to the liver. The starting dose was 600–800 mg/m2 per day; cycles were repeated at 4-week intervals. The 5-FU dose was increased by 250 mg/day at each cycle. All six patients received 3 or more cycles, for a total of 37 cycles. Response was evaluated after each cycle by ultrasonography or computed tomography (CT). Pharmacokinetic data revealed a high individual cycle-to-cycle variability for all six patients in the 5-FU area under the curve (AUC day 1 to day 5) corrected for the dose. These variations in drug biodisposition, reflecting hepatic 5-FU uptake, were significantly related to measurable modifications in the tumor mass in 71% of cycles. The correlation between the reduction in local drug exposure and tumor regrowth was better than that between the increase in local drug exposure and tumor reduction. These findings constitute an original illustration in humans of the experimental concept of the drug exposure/tumor response relationship for 5-FU.Keywords
This publication has 16 references indexed in Scilit:
- Clinical pharmacokinetic study of 5-FU in continuous 5-day infusions for head and neck cancerCancer Chemotherapy and Pharmacology, 1986
- Continuous 5-day regional chemotherapy by 5-fluorouracil in colon carcinoma: Pharmacokinetic evaluationBritish Journal of Cancer, 1985
- Adjuvant treatment of colorectal cancerCancer Chemotherapy and Pharmacology, 1985
- Prognostic factors influencing survival of patients with advanced colorectal cancer: hepatic-artery infusion versus systemic intravenous chemotherapy for liver metastases.Journal of Clinical Oncology, 1984
- Increasing therapeutic response rates to anticancer drugs by applying the basic principles of pharmacologyPharmacology & Therapeutics, 1983
- Regional chemotherapy of neoplastic diseasesPharmacology & Therapeutics, 1983
- BIOCHEMICAL DETERMINANTS OF RESPONSIVENESS TO 5-FLUOROURACIL AND ITS DERIVATIVES IN XENOGRAFTS OF HUMAN COLORECTAL ADENOCARCINOMAS IN MICE1981
- Biochemical pharmacology in medical oncology.1981
- Clinical response and plasma levels of 5-fluorouracil in patients with colonic cancer treated by drug infusionBritish Journal of Cancer, 1978
- The blood supply of experimental liver metastases. I. The distribution of hepatic artery and portal vein blood to "small" and "large" tumors.1969